13F reference period
Q2 2026
Security Snapshot
Rallybio Corp - Common Stock, par value $0.0001 per share (RLYB) Institutional Ownership
CUSIP: 75120L209
13F Institutional Holders and Ownership History from Q4 2025 to Q3 2026
Institutions Reporting
37
Shares (Excl. Options)
4.07M
Full value: 4,065,193 · shares · 30 Jun 2026Price
$16.00
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- RLYB on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 4,065,193
- Total 13F value
- $65,042,690
- Portfolio coverage rank
- 0%
- Share change
- -601,214
- Value change
- +$2,230,130
- Number of holders
- 37
- Shares outstanding
- 5,292,753
- SEC-reported price per share
- $16.99
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- RLYB - Rallybio Corp - Common Stock, par value $0.0001 per share is tracked under CUSIP 75120L209.
- 37 institutions reported positions in Q2 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 38 to 37 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$41.85M
Full value: $41,853,824 · USD · 31 Mar 2026.$65.04M
Full value: $65,042,690 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 37 institutions filings for Q2 2026.
Security key
75120L209
13F reference period
Q2 2026
13F holders
37
13D/G owners
4
CIK / CUSIP context first
Open Q2 2026 holders
RLYB full holder history
Rallybio Corp SEC filings
Rallybio Corp company facts
Rallybio Corp insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 75120L209:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
RLYB
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 18% | $13,293,151 | 926,352 | ADAR1 Capital Management, LLC | 31 May 2026 | |||
| FMR LLC | 15% | +40% | $12,715,520 | +$3,726,752 | 794,720 | +41% | FMR LLC | 30 Jun 2026 |
| 5AM Ventures V, L.P. | 5.5% | 291,788 | Andrew J. Schwab | 25 Feb 2026 | ||||
| Nantahala Capital Management, LLC | 3.6% | $3,014,752 | 188,422 | Nantahala Capital Management, LLC | 30 Jun 2026 |
As of 30 Jun 2026,
37
institutional investors reported holding
shares of
Rallybio Corp - Common Stock, par value $0.0001 per share (RLYB).
This represents
77%
of the company’s total
outstanding shares.
4.07M
Full value: 4,065,193 · shares · 30 Jun 20265.29M
Full value: 5,292,753 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
77%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 18% | 926,352 | +4411% | 0.7% | $14,821,632 |
| FMR LLC | 15% | 794,720 | +0.16% | 0% | $12,715,520 |
| VIKING GLOBAL INVESTORS LP | 9.9% | 524,347 | 0% | 0.02% | $8,389,552 |
| TPG GP A, LLC | 7.2% | 378,551 | 0% | 0.12% | $6,056,816 |
| Pivotal bioVenture Partners Investment Advisor LLC | 5.7% | 300,579 | 0% | 1.6% | $4,809,264 |
| RENAISSANCE TECHNOLOGIES LLC | 3.8% | 199,907 | +28% | 0% | $3,198,512 |
| Nantahala Capital Management, LLC | 3.6% | 188,422 | -37% | 0.18% | $3,014,752 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.3% | 172,497 | +54% | 0% | $2,759,952 |
| Almitas Capital LLC | 2.3% | 120,682 | -37% | 0.46% | $1,930,912 |
| Rangeley Capital, LLC | 2% | 104,850 | +248% | 1.6% | $1,677,600 |
| CITADEL ADVISORS LLC | 1.4% | 72,200 | +263% | 0% | $1,155,200 |
| Mariner, LLC | 0.96% | 50,566 | 0% | 0% | $809,056 |
| JANE STREET GROUP, LLC | 0.9% | 47,423 | 0% | $758,768 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.61% | 32,047 | -9.5% | 0% | $512,865 |
| BlackRock, Inc. | 0.57% | 30,332 | +73% | 0% | $485,312 |
| HRT FINANCIAL LP | 0.48% | 25,657 | 0% | $410,000 | |
| XTX Topco Ltd | 0.41% | 21,497 | +91% | 0% | $343,952 |
| VANGUARD FIDUCIARY TRUST CO | 0.32% | 16,820 | +24% | 0% | $269,120 |
| TWO SIGMA INVESTMENTS, LP | 0.31% | 16,619 | 0% | $265,904 | |
| STATE STREET CORP | 0.25% | 12,996 | 0% | $207,936 | |
| Quadrature Capital Ltd | 0.25% | 12,995 | 0% | $207,920 | |
| DIMENSIONAL FUND ADVISORS LP | 0.21% | 11,280 | 0% | 0% | $180,480 |
| Vanguard Global Advisers, LLC | 0.03% | 1,442 | 0% | 0% | $23,072 |
| Hartford Financial Management Inc. | 0.02% | 812 | 0% | 0% | $12,992 |
| SBI Securities Co., Ltd. | 0.01% | 506 | -3.4% | 0% | $8,096 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
4
Headline period
Q2 2026
Rows shown
1-4 of 4